If you've ever looked up the price of Wegovy or Zepbound at your local pharmacy without insurance, you know the feeling — somewhere between shock and disbelief. $1,000 to $1,350 for a single monthly supply. And if your insurance denied your prior authorization (which happens to more than 60% of first-time applicants), it probably felt like your only options were paying full price or giving up.

You're not out of options. Here's the key fact most people get wrong from the start: the price at the pharmacy counter is not the price you have to pay. It's the "list price," and it exists almost entirely for insurance billing purposes. The real out-of-pocket price can be dramatically lower if you know where to look.

Strategy 1: manufacturer savings cards (start here)

Both Eli Lilly (Zepbound, Mounjaro) and Novo Nordisk (Wegovy, Ozempic) offer official savings cards directly on their websites. These are not sketchy third-party coupons — they're manufacturer programs that can bring your monthly cost down to:

  • As low as $25/month for commercially insured patients (even if your plan doesn't cover GLP-1s);
  • $200–550/month for uninsured patients, depending on income and situation.
Critical detail: if you're on Medicare or Medicaid, these cards legally cannot be used. But don't stop reading — the patient assistance programs below may apply to you, and since July 1, 2026, Medicare Part D covers GLP-1s at $50/month.

Enroll directly on the manufacturer sites (search for the official Wegovy or Zepbound savings program — don't use random coupon sites). It takes about 3 minutes and the card works the same day at most pharmacies. And a note on GoodRx: it's great for many medications, but for brand-name GLP-1s the manufacturer cards almost always beat it by a wide margin. Check both, but don't assume.

Strategy 2: compounded GLP-1s through telehealth ($150–350/month)

A growing number of telehealth providers offer compounded semaglutide and tirzepatide — the same active molecules, prepared by FDA-registered compounding pharmacies rather than by Novo Nordisk or Eli Lilly. The price difference is substantial: $150–350 per month versus $1,000+ for the brand name.

But this matters for your safety: not all compounding pharmacies are equal. Use only providers that source from 503B registered outsourcing facilities — the FDA-regulated tier operating under the strictest quality standards — with real physician oversight included. That's the combination of price, safety and supervision you're looking for, and it's exactly what we screen for in our platform ranking.

What to avoid: random online pharmacies or social media sellers offering injectable semaglutide with no prescription and no medical supervision. Regulators have already seized multiple batches of counterfeit GLP-1 products sold through Instagram and TikTok. If the price seems impossibly low and there's no doctor involved, walk away.

Strategy 3: patient assistance programs (potentially $0)

Almost nobody talks about this one. Beyond the savings cards, both manufacturers run full patient assistance programs for people whose income makes the drug genuinely unaffordable: Novo Nordisk's Patient Assistance Program and the Lilly Cares Foundation.

Eligibility is income-based — typically a household income under 400% of the federal poverty level with no insurance coverage for the drug. Qualifying patients can receive the medication at little to no cost, directly from the manufacturer. These programs are real, legitimate, and massively underutilized simply because people don't know they exist. You apply directly on the manufacturers' websites.

Strategy 4: dose optimization (talk to your doctor)

Once you've gone through dose titration and reached maintenance, the cost per unit often doesn't scale linearly with dose. Some providers support "dose optimization" — working with your doctor to find the lowest effective dose that maintains your results. This isn't rationing; it's precision. European obesity specialists build this conversation into standard protocol, and some US telehealth platforms are adopting it too.

The hidden fees that turn $249 into $550

Whatever platform you choose, the advertised price is rarely the whole story. Here's the checklist of what to verify before entering your card details:

Hidden costTypical rangeWhat to ask
Dose-tier pricingCan double or triple your bill"What will I pay at the maintenance dose?" Prefer flat-rate pricing.
Membership / platform fee$20–99/month"Is there any fee separate from the medication price?"
Follow-up consultations$50–150 per visit"Are follow-ups and messaging included?"
Cold-chain shipping$30–50 per shipment"Is refrigerated shipping included?"
Lab work$150–400 per panel"What labs are required, and who pays?"
Injection suppliesVaries"Are needles and swabs included?"

A real example of how it adds up: you sign up at an advertised $249/month for tirzepatide. Two months in, a higher dose adds $100. There's a $30 monthly platform fee you missed. Shipping isn't included — $480/year. One paid follow-up: $75. That "$249 program" is now closer to $550/month in year one. That's the math they don't want you doing.

Putting it all together

StepMonthly cost
Uninsured pharmacy list price (branded)$1,000–1,350
Switch to a telehealth platform using a 503B compounding pharmacy~$150–350
Qualify for a manufacturer patient assistance programPotentially $0

Net result: from over $1,000 to somewhere between $0 and $350 depending on your situation — the $500+ monthly savings zone. Every step is legal, safe, and available today.

What to do right now

  1. Enroll in the manufacturer savings card — 3 minutes, costs nothing, works even if you never use it.
  2. Compare vetted telehealth platforms with compounded options and proper medical oversight — start with our weekly price tracker and 2026 ranking.
  3. If cost is a serious barrier, apply to the patient assistance programs (Novo Nordisk PAP / Lilly Cares).

Medical disclaimer: this guide covers costs and services, not medical advice. GLP-1 therapy is prescription treatment — always consult a licensed healthcare provider.